The Specialty-First Flywheel Strategy

Cardinal Health is in the middle of a multi-billion-dollar pivot: away from being "just" a pharmaceutical distributor and toward owning a flywheel of specialty drug distribution + physician practice management (MSOs) + biopharma services. By FY26, specialty revenue is targeted to surpass $50 billion. This module walks candidates through the flywheel logic, the three big acquisitions that built it (GI Alliance, Solaris Health, Advanced Diabetes Supply Group), and how to talk about it in a "Why Cardinal Health?" answer.